Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
Quality Operations
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Price Sensitive Information
2024-2025 First Quarter
Read More
2023-2024 Corporate Declaration
Read More
2023-2024 3rd Quarter
Read More
2023-2024 2nd Quarter
Read More
Credit Rating Report 2023
Read More
2023-2024 1st Quarter
Read More
2022-2023 Corporate Declaration
Read More
2022-2023 3rd Quarter
Read More
2022-2023 2nd Quarter
Read More
Credit Rating Report 2022
Read More
2022-2023 1st Quarter
Read More
2021-2022- Corporate Declaration
Read More
2021-2022 3rd Quarter
Read More
2021-2022 2nd Quarter
Read More
2021-2022 1st Quarter
Read More
2020-2021 Corporate Declaration
Read More
Revaluation as at 30 June 2021
Read More
2020-2021 3rd Quarter(Un-Audited)
Read More
2020-2021 2nd Quarter
Read More
2020-2021 1st Quarter
Read More
2019-2020 Corporate Declaration
Read More
Launching of Zolpidem tablet in the US Market
Read More
2019-2020 3rd Quarter (Un-Audited)
Read More
2019-2020 2nd Quarter
Read More
2019-2020 1st Quarter
Read More
2018-2019 Corporate Declaration
Read More
Commencement of Commercial Production of Steroid and Hormone facility
Read More
Commencement of Commercial Production of Penicillin facility
Read More
2018-2019 3rd Quarter
Read More
2018-2019 Achieved Certificate of GMP Compliance from UK MHRA
Read More
2018-2019 2nd Quarter
Read More
2018-2019 1st Quarter
Read More
2017-2018 Corporate Declaration
Read More
2017-2018 3rd Quarter
Read More
2017-2018 2nd Quarter
Read More
2017-2018 1st Quarter
Read More
2016-2017 Corporate Declaration
Read More
July 2017- Upgradation of ISO Standard
Read More
2016-2017 3rd Quarter
Read More
2016-2017 2nd Quarter
Read More
2016-2017 1st Quarter
Read More
2015-2016 Corporate Declaration
Read More
September 2016-Assets Revaluation
Read More
